The Nicotinic Cholinergic System and Cognitive Aging

烟碱胆碱能系统和认知衰老

• 批准号: 9273350
• 负责人: JULIE A DUMAS
• 金额: $ 37.51万
• 依托单位: UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-05-15 至 2021-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9273350
• 关键词: Activities of Daily Living; Address; Adult; Affect; Age; Aging; Area; Attention; Brain; Clinical Trials; Cognition; Cognitive; Cognitive Science; Cognitive aging; Data; Decision Making; Dementia; Disease; Elderly; Frontal gyrus; Functional Imaging; Functional Magnetic Resonance Imaging; Functional disorder; Future; Impaired cognition; Impairment; Institute of Medicine (U.S.); Medial; Memory; Methods; Modeling; Neurobehavioral Manifestations; Neurobiology; Neurons; Neurotransmitters; Nicotine; Nicotinic Receptors; Nootropic Agents; Normal Range; Pattern; Performance; Pharmacology; Placebos; Play; Problem Solving; Public Health; Research; Role; Short-Term Memory; Societies; Structure; System; Task Performances; Testing; Therapeutic; Work; age difference; age effect; age related; age related cognitive change; aging brain; aging population; base; cholinergic; cognitive function; cognitive process; cognitive task; falls; financial decision making; healthy aging; improved; memory encoding; mild cognitive impairment; neurochemistry; neuron loss; non-demented; normal aging; novel; older women; psychological aspect of aging; psychopharmacologic; public health relevance; receptor function; remediation; response; theories; young adult

 DESCRIPTION (provided by applicant): The cholinergic system has been shown to be the primary neurotransmitter system responsible for cognitive symptoms in dementia. While therapeutic benefits are clear in dementia, what remains uncertain is the role that the cholinergic system in general and the nicotinic system specifically plays in cognition in healthy non-demented older adults (referred to as cognitive aging in this application). This is critical becaus the expansion of the healthy aging population will nonetheless show declines in cognition that fall short of dementia but still impact functional abilities, independence, and financial decision making. Understanding the effects of age-related functional changes on the nicotinic system will elucidate one neurochemical mechanism underlying age-related changes in cognition and will provide information about how nicotinic dysfunction affects cognition in healthy older adults. Prior research has shown that the nicotinic system has a roll in attention and memory in healthy adults. More recently, with the increased use of brain functional magnetic resonance imaging (fMRI) in combination with psychopharmacological manipulations, data patterns have emerged that further define the role of the nicotinic system in cognition, aging, and dementia. We propose that nicotinic system changes are responsible for age differences in working memory task performance and brain activation. We can observe the functioning of the nicotinic system by examining brain activation patterns in response to nicotinic blockade and stimulation. Increased medial frontal gyrus (MFG) activation has been shown in older adults compared to younger adults. We propose that temporary antagonism of the nicotinic system will model this "older pattern" of impaired performance and increased MFG activation. We hypothesize that older adults will have greater performance impairments and increased MFG activation compared to younger adults after nicotinic blockade. We also propose that nicotinic stimulation will result in "younger patterns" of better performance and decreased MFG activation. We hypothesize that nicotinic stimulation will improve performance and this improvement will be greater for older adults compared to younger adults. We will also observe decreased MFG activation that will be greater for older adults compared to younger adults. These data will further the understanding of one neurochemical mechanism involved in normal aging and how brain activation patterns relate to receptor function. As the search continues for safe and effective cognitive enhancers, it will be important to understand the role of the nicotinic system in cognitive aging and whether nicotinic mechanisms have the potential to benefit cognition in healthy adults.

 描述(申请人提供)：胆碱能系统已被证明是导致痴呆症认知症状的主要神经递质系统。虽然治疗痴呆症的益处是显而易见的，但仍然不确定的是胆碱能 一般情况下，尼古丁系统和尼古丁系统在健康的非痴呆老年人的认知中发挥特殊作用(在本申请中称为认知老化)。这一点至关重要，因为健康老龄化人口的扩张仍将显示出认知能力的下降，这些认知能力低于痴呆症，但仍会影响功能能力、独立性和财务决策。了解与年龄相关的功能变化对尼古丁系统的影响将有助于阐明与年龄相关的认知变化背后的神经化学机制，并将提供有关尼古丁功能障碍如何影响健康老年人认知的信息。先前的研究表明，尼古丁系统对健康成年人的注意力和记忆力有促进作用。最近，随着脑功能磁共振成像(FMRI)与精神药理操作结合使用的增加，出现了进一步定义尼古丁系统在认知、衰老和痴呆中的作用的数据模式。我们认为，尼古丁系统的变化是工作记忆、任务表现和大脑激活的年龄差异的原因。我们可以通过检测大脑对尼古丁阻断和刺激的激活模式来观察尼古丁系统的功能。与年轻人相比，老年人的内侧额回(MFG)激活增加。我们认为，尼古丁系统的暂时性拮抗将模拟这种表现受损和MFG激活增加的“旧模式”。我们假设，与年轻人相比，在尼古丁阻断后，老年人将有更大的操作障碍和更高的MFG激活。我们还提出，尼古丁刺激将导致更好的表现和减少MFG激活的“年轻模式”。我们假设尼古丁刺激会改善运动能力，与年轻人相比，这种改善对老年人的影响更大。我们还将观察到MFG活性降低，与年轻人相比，老年人的MFG激活程度更大。这些数据将进一步了解正常衰老涉及的一种神经化学机制，以及大脑激活模式如何与受体功能相关。随着对安全有效的认知增强剂的研究的继续，了解尼古丁系统在认知老化中的作用以及尼古丁机制是否有可能有益于健康成年人的认知将是重要的。